Cara Therapeutics, Inc. (CARA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 11.08 |
| Open | 11.09 |
| Bid | 9.50 x 800 |
| Ask | 12.09 x 800 |
| Day's range | 11.09 - 12.01 |
| 52-week range | 7.40 - 13.97 |
| Volume | |
| Avg. volume | 362,015 |
| Market cap | 624.398M |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | 65.99 |
| EPS (TTM) | 0.18 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.00 |
- Simply Wall St.
Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week, taking three-year losses to 35%
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...
- Simply Wall St.
Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations
Cara Therapeutics ( NASDAQ:CARA ) Third Quarter 2022 Results Key Financial Results Revenue: US$10.8m (down 47% from 3Q...
- Zacks
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of -2.38% and 28.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
